Ikeda N, Kojima H, Nishikawa M, Hayashi K, Futagami T, Tsujino T, et al. Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens. 2015;85(4):252–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320(4):197–204.

Article  CAS  PubMed  Google Scholar 

Ikegame K, Kaida K, Yoshihara S, Fujiwara M, Taniguchi K, Kato R, et al. Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients. Int J Hematol. 2012;96(1):101–8.

Article  CAS  PubMed  Google Scholar 

Kanda J, Ikegame K, Fuji S, Kurokawa M, Kanamori H, Fukuda T, et al. Haploidentical and matched sibling donor hematopoietic cell transplantation for patients with HLA-homozygous haplotypes. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2016;22(11):2031–7.

Article  Google Scholar 

Satake A, Inoue T, Kubo S, Taniguchi Y, Imado T, Fujioka T, et al. Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells. Int J Hematol. 2010;91(3):485–97.

Article  CAS  PubMed  Google Scholar 

Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86(3):269–74.

Article  PubMed  Google Scholar 

Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825–8.

CAS  PubMed  Google Scholar 

Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28(3):250–9.

CAS  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.

Article  CAS  PubMed  Google Scholar 

Clancy J, Hyvärinen K, Ritari J, Wahlfors T, Partanen J, Koskela S. Blood donor biobank and HLA imputation as a resource for HLA homozygous cells for therapeutic and research use. Stem Cell Res Ther. 2022;13(1):502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin S, Song EY, Kwon YW, Oh S, Park H, Kim NH, et al. Usefulness of the hematopoietic stem cell donor pool as a source of HLA-homozygous induced pluripotent stem cells for haplobanking: combined analysis of the cord blood inventory and bone marrow donor registry. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2020;26(8):e202–8.

Article  CAS  Google Scholar 

Morishima Y, Azuma F, Kashiwase K, Matsumoto K, Orihara T, Yabe H, et al. Risk of HLA homozygous cord blood transplantation: implications for induced pluripotent stem cell banking and transplantation. Stem Cells Transl Med. 2018;7(2):173–9.

Article  CAS  PubMed  Google Scholar 

Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, et al. Unmanipulated haploidentical reduced-intensity stem cell transplantation using fludarabine, busulfan, low-dose antithymocyte globulin, and steroids for patients in non-complete remission or at high risk of relapse: a prospective multicenter phase I/II study in Japan. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2015;21(8):1495–505.

Article  CAS  Google Scholar 

Kaida K, Ikegame K, Inoue T, Maruyama S, Ishii S, Uchida N, et al. Peritransplantation glucocorticoid haploidentical stem cell transplantation is a promising strategy for AML patients with high leukemic burden: comparison with transplantations using other donor types. Transplant Cell Ther. 2023;29(4):273.e1-273.e9.

Article  CAS  PubMed  Google Scholar